Bamboo fibres and their unique properties

This paper collates the different properties of bamboo fibres as claimed by bamboo fibre and product manufacturers. The available information suggests that bamboo fibres have unique properties such as excellent appearance and feel, natural antibacterial, UV-shielding and moisture-controlling characteristics. Hence bamboo fibres provide a very promising alternative to other natural fibres by virtue of their novel properties. However, those properties may largely depend on the manufacturing process, which is not widely disclosed. Moreover, common manufacturing process may require the use of a large amount of chemicals and hence further process development may be required in order to make the product truly eco-friendly. It is identified that the data of those unique properties rarely appear in scientific journals and the validity of those claims can be speculative. Therefore, there is a strong need for non-biased scientific research and evaluation on the unique properties of bamboo fibres.<br /

Bamboo : a distinctive green fibre

This article reports the preliminary findings on the morphology, chemical structure, antimicrobial and UV-screening properties of bamboo fibres. Bamboo fibres provide a very promising alternative to other natural fibres by virtue of their distinctive characteristics such as eco-friendly farming, inherent antimicrobial, UV-protective and highly&middot; breathable properties. However, these novel properties are moslly claimed by fibre manufacturers, with little scientific evidence.&nbsp; Moreover, those properties may largely depend on the manufacturing process, which is not widely disclosed by the manufacturers, Common manufacturing processes may require the use of a large amount of chemicals which would not make the product truly eco-friendly. Therefore, there is a strong need for unbiased laboratory experiments being conducted in a rigorous manner to elucidate the origin of those unique properties of bamboo fibres and to develop new processing methods to effectively utilise the properties in the final products. This research is aimed to prove the unique characteristics of bamboo fibres scientifically and to develop an efficient manufacturing process, in order to establish the place of bamboo fibres as a novel green material.<br /

Bamboo fibres and their unique properties

This paper collates the different properties of bamboo fibres as claimed by bamboo fibre and product manufacturers. The available information suggests that bamboo fibres have unique properties such as excellent appearance and feel, natural antibacterial, UV-shielding and moisture-controlling characteristics. Hence bamboo fibres provide a very promising alternative to other natural fibres by virtue of their novel properties. However, those properties may largely depend on the manufacturing process, which is not widely disclosed. Moreover, common manufacturing process may require the use of a large amount of chemicals and hence further process development may be required in order to make the product truly eco-friendly. It is identified that the data of those unique properties rarely appear in scientific journals and the validity of those claims can be speculative. Therefore, there is a strong need for non-biased scientific research and evaluation on the unique properties of bamboo fibres.<br /

The origin of the antibacterial property of bamboo

Bamboo is an eco-friendly and multifunctional plant. Bamboo clothing has recently entered the textile market with a claim for its antimicrobial properties, but without scientific evidence. In this study, the antibacterial activity of plant extracts from Australian-grown bamboo (Phyllostachys pubescens) is investigated. Bamboo extracts were made using water, dimethyl sulphoxide (DMSO) and dioxane and their antibacterial properties were compared against Gram-negative bacteria, Escherichia coli. It was found that the extract made in 20% DMSO aqueous solution showed weak antibacterial activity, whereas the extract made using 90% dioxane aqueous solution exhibited strong antibacterial activity, even after 20 times dilution. The results indicate that antibacterial agents of P. pubescens are located in lignin, not in hemicellulose or other water-soluble chemical components

Post-HPV-vaccination mast cell activation syndrome: Possible vaccine-triggered escalation of undiagnosed pre-existing mast cell disease?

For nearly a decade, case reports and series have emerged regarding dysautonomias-particularly postural orthostatic tachycardia syndrome (POTS)-presenting soon after vaccination against human papilloma virus (HPV). We too have observed a number of such cases (all following vaccination with the Gardasil product), and have found several to have detectable mast cell activation syndrome (MCAS) as well as histories suggesting that MCAS was likely present long before vaccination. We detail 11 such cases here, posing a hypothesis that HPV vaccination (at least with the Gardasil product) may have triggered or exacerbated MCAS in teenagers previously not recognized to have it. Only recently recognized, MCAS is being increasingly appreciated as a prevalent and chronic multisystem disorder, often emerging early in life and presenting with inflammatory ± allergic phenomena following from known mast cell (MC) mediator effects. There is rising recognition, too, of associations of MCAS with central and peripheral neuropathic disorders, including autonomic disorders such as POTS. Given the recognized potential for many antigens to trigger a major and permanent escalation of baseline MC misbehavior in a given MCAS patient, we hypothesize that in our patients described herein, vaccination with Gardasil may have caused pre-existing (but not yet clinically recognized) MCAS to worsen to a clinically significantly degree, with the emergence of POTS and other issues. The recognition and management of MCAS prior to vaccinations in general may be a strategy worth investigating for reducing adverse events following HPV vaccinations and perhaps even other types of vaccinations

Calibration of the LIGO displacement actuators via laser frequency modulation

We present a frequency modulation technique for calibration of the displacement actuators of the LIGO 4-km-long interferometric gravitational-wave detectors. With the interferometer locked in a single-arm configuration, we modulate the frequency of the laser light, creating an effective length variation that we calibrate by measuring the amplitude of the frequency modulation. By simultaneously driving the voice coil actuators that control the length of the arm cavity, we calibrate the voice coil actuation coefficient with an estimated 1-sigma uncertainty of less than one percent. This technique enables a force-free, single-step actuator calibration using a displacement fiducial that is fundamentally different from those employed in other calibration methods.Comment: 10 pages, 5 figures, submitted to Classical and Quantum Gravit

Antidiabetic Effects of Momordica Charantia (Karela) in Male Long Evans Rat

The hypoglycemic effect of Momordica charantia (Karela) has been reported from many laboratories. To our knowledge, the underlying biochemical mechanism of action of this important clinical effect has not been reported. During the course of investigation of this aspect of the herbal fruit, it was reported from our laboratory that ethanolic extract of Momordica charantia suppressed gluconeogenesis in normal and streptozotocin (STZ) induced diabetic rats by depressing the hepatic gluconeogenic enzymes fructose-1,6-bisphosphatase and glucose-6-phosphatase. The herbal extract had also enhanced the activity of glucose-6-phosphate dehydrogenase, the rate-limiting enzyme of hexose monophosphate shunt (a pathway for the oxidation of glucose)

Workflow to improve patient recruitment for clinical trials within hospital information systems – a case-study

<p>Abstract</p> <p>Background</p> <p>The identification of suitable patients is a common problem in clinical trials that is especially evident in tertiary care hospitals.</p> <p>Methods</p> <p>We developed and analysed a workflow, which uses routine data captured during patient care in a hospital information system (HIS), to identify potential trial subjects. Study nurses or physicians are notified automatically by email and verify eligibility.</p> <p>Results</p> <p>As a case study we implemented the system for acute myeloid leukemia (AML) trials in Münster. During a test period of 50 days 41 patients were identified by the system. 13 could be included as new trial patients, 7 were already included during earlier visits. According to review of paper records no AML trial patient was missed by the system. In addition, the hospital information system further allowed to preselect patients for specific trials based on their disease status and individual characteristics.</p> <p>Conclusion</p> <p>Routine HIS data can be used to support patient recruitment for clinical trials by means of an automated notification workflow.</p